Deciding to Initiate Antiviral Treatment in Patients with Chronic Hepatitis B Virus Infection
This answer is correct. According to current guidelines for hepatitis B therapy, this patient should receive antiviral therapy for chronic hepatitis B. He has chronic hepatitis B infection in the immune active phase, with a positive HBeAg, a high HBV DNA level, and persistently elevated ALT. His bilirubin, platelet count, and INR are all within normal limits, and he does not have a clinical history or laboratory findings consistent with decompensated cirrhosis.